SEC Comment Letter 0000000000-23-012761 to DOC.COM INC. (CIK 0001925674)
DOC.COM INC. (CIK 0001925674)
Date: Nov. 21, 2023 · CIK: 0001925674 · Accession: 0000000000-23-012761
AI Filing Summary & Sentiment
File numbers found in text: 024-12337
Letter
United States securities and exchange commission logo November 21, 2023 Charles Nader Chief Executive Officer Doc.com Inc. 408 Broadway New York, NY 10013 Re:Doc.com Inc. Amendment No. 1 to Offering Statement on Form 1-A Filed November 9, 2023 File No. 024-12337 Dear Charles Nader: We have reviewed your amended offering statement and have the following comments. Please respond to this letter by amending your offering statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your offering statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our November 2, 2023 letter. Form 1-A filed November 9, 2023 Business, page 17 1.We note your response to prior comment 4 and reissue in part. Please describe the legal relationship between you and the physicians, psychologists, and veterinarians on your app, or to the extent you this has not yet been determined, discuss any uncertainty in that regard. Disclose whether you have signed any agreements for the employment of doctors for your app. Additionally, please disclose your anticipated timeline for the final testing and launching of your app. Principal Shareholders, page 22 2.Given the substantial voting power of class B shares, please revise your beneficial ownership table to add a column disclosing the aggregate voting power held by each person listed in the table.
FirstName LastNameCharles Nader Comapany NameDoc.com Inc. November 21, 2023 Page 2 FirstName LastName Charles Nader Doc.com Inc. November 21, 2023 Page 2 Please contact Lauren Pierce at 202-551-3887 or Matthew Derby at 202-551-3334 with any questions. Sincerely, Division of Corporation Finance Office of Technology cc: Andy Altahawi
Show Raw Text
United States securities and exchange commission logo
November 21, 2023
Charles Nader
Chief Executive Officer
Doc.com Inc.
408 Broadway
New York, NY 10013
Re:Doc.com Inc.
Amendment No. 1 to Offering Statement on Form 1-A
Filed November 9, 2023
File No. 024-12337
Dear Charles Nader:
We have reviewed your amended offering statement and have the following comments.
Please respond to this letter by amending your offering statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your offering statement and the information you
provide in response to this letter, we may have additional comments. Unless we note otherwise,
any references to prior comments are to comments in our November 2, 2023 letter.
Form 1-A filed November 9, 2023
Business, page 17
1.We note your response to prior comment 4 and reissue in part. Please describe the legal
relationship between you and the physicians, psychologists, and veterinarians on your app,
or to the extent you this has not yet been determined, discuss any uncertainty in that
regard. Disclose whether you have signed any agreements for the employment of doctors
for your app. Additionally, please disclose your anticipated timeline for the final testing
and launching of your app.
Principal Shareholders, page 22
2.Given the substantial voting power of class B shares, please revise your beneficial
ownership table to add a column disclosing the aggregate voting power held by each
person listed in the table.
FirstName LastNameCharles Nader
Comapany NameDoc.com Inc.
November 21, 2023 Page 2
FirstName LastName
Charles Nader
Doc.com Inc.
November 21, 2023
Page 2
Please contact Lauren Pierce at 202-551-3887 or Matthew Derby at 202-551-3334 with
any questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Andy Altahawi